Stock Price Quote

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3355.8538.4 (+1.16 %)
PREV CLOSE ( ) 3317.45
OPEN PRICE ( ) 3317.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18834
TODAY'S LOW / HIGH ( )3300.40 3417.50
52 WK LOW / HIGH ( )3197 4640.95
NSE3356.8541.55 (+1.25 %)
PREV CLOSE( ) 3315.30
OPEN PRICE ( ) 3332.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3356.85 (204)
VOLUME 501235
TODAY'S LOW / HIGH( ) 3300.30 3419.00
52 WK LOW / HIGH ( )3195.15 4640.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

25Jan Divi’s Laboratories informs about conf
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
24Dec Divi's Laboratories informs about trad
Divi's Laboratories has informed that the Trading Window for trading in..
24Dec Divi's Laboratories informs about news
Divi's Laboratories has informed that it enclosed copies of newspaper ad..
08Nov Divi's Laboratories reports 19% fall i
Divi's Laboratories has reported results for second quarter ended Septem..
28Oct Divi's Laboratories informs about boar
Divi's Laboratories has informed that the meeting of the Board of Direct..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit4868.529485.4
Gross Profit 6029 36765.2
Operating Profit 6885.139877.2
Net Sales 18233.888798.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  1528.90 (3.12%)
M.Cap ( in Cr)944.56
Astrazeneca Pharma I (BSE)
peergroup  3384.85 (0.88%)
M.Cap ( in Cr)8462.13
Dr. Reddy's Lab (BSE)
peergroup  4350.50 (0.61%)
M.Cap ( in Cr)72446.11
Alkem Laboratories (BSE)
peergroup  3033.10 (0.78%)
M.Cap ( in Cr)36265.26
Cipla (BSE)
peergroup  1032.30 (1.50%)
M.Cap ( in Cr)83321.47

Shareholding Pattern

FI/BANKS/INSURANCE 6.88%
PROMOTERS 51.94%
MUTUAL FUNDS/UTI 12.68%
NON-INSTITUTION 12.24%
GOVERNMENT 0%
FII 0%

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd. was incorporated in the year 1990. Its today's share price is 3355.85. Its current market capitalisation stands at Rs 89087.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 89236.6 Cr and Total Income of Rs.89938.5 Cr. The company's management includes Satish Choudhury, K V Chowdary, Sunaina Singh, S Ganapaty, KVK Seshavataram, R Ranga Rao, G Suresh Kumar, Ramesh BV Nimmagadda, Madhusudana Rao Divi, Nilima Prasad Divi, Kiran S Divi, N V Ramana, Murali K Divi.

It is listed on the BSE with a BSE Code of 532488 , NSE with an NSE Symbol of DIVISLAB and ISIN of INE361B01024. It's Registered office is at 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,GachibowliHyderabad-500032, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Price Waterhouse Chartered Accountants LLP, PVRK Nageswara Rao & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)